Predictors of


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
08 2022
Historique:
received: 26 03 2021
accepted: 02 12 2021
pubmed: 18 12 2021
medline: 4 8 2022
entrez: 17 12 2021
Statut: ppublish

Résumé

Our objective was to investigate the factors predicting scan positivity and disease location in patients with biochemical recurrence (BCR) of prostate cancer (PCa) after primary local therapy using prostate-specific membrane antigen-targeted

Identifiants

pubmed: 34916246
pii: jnumed.121.262347
doi: 10.2967/jnumed.121.262347
pmc: PMC9364352
doi:

Substances chimiques

Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1184-1190

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Références

J Urol. 2007 Feb;177(2):540-5
pubmed: 17222629
Mol Imaging Biol. 2015 Aug;17(4):565-74
pubmed: 25896814
Ann Nucl Med. 2021 Apr;35(4):523-528
pubmed: 33661475
J Nucl Med. 2020 Jun;61(6):881-889
pubmed: 31676732
Lancet Oncol. 2011 Feb;12(2):181-91
pubmed: 20599424
J Urol. 2018 Jan;199(1):126-132
pubmed: 28736318
Ann Transl Med. 2017 May;5(10):211
pubmed: 28603726
J Nucl Med. 2016 Jan;57(1):46-53
pubmed: 26493203
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1626-1638
pubmed: 33604691
J Nucl Med. 2019 Mar;60(3):362-368
pubmed: 30042163
Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):822-8
pubmed: 23845839
Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1911-1918
pubmed: 31230088
Semin Nucl Med. 2019 Jul;49(4):255-270
pubmed: 31227049
Eur Urol Oncol. 2022 Feb;5(1):100-103
pubmed: 33602654
J Cell Biochem. 2004 Feb 15;91(3):528-39
pubmed: 14755683
Eur Urol. 2014 Jun;65(6):1034-43
pubmed: 23972524
BJU Int. 2011 Aug;108(3):378-85
pubmed: 21091976
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):136-146
pubmed: 31492993
Eur Urol. 2018 May;73(5):656-661
pubmed: 29358059
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74
pubmed: 16798415
Urol Oncol. 2015 Apr;33(4):163.e7-13
pubmed: 25665508
J Nucl Med. 2018 Feb;59(2):230-237
pubmed: 29123013
J Nucl Med. 2021 Sep 1;62(9):1252-1257
pubmed: 33547214
J Nucl Med. 2017 Jul;58(7):1081-1087
pubmed: 28209912
J Nucl Med. 2021 Mar 12;:
pubmed: 33712531
J Nucl Med. 2019 Sep;60(9):1253-1258
pubmed: 30902875
J Nucl Med. 2019 Nov;60(11):1587-1593
pubmed: 30979820
J Nucl Med. 2021 Nov;62(11):1550-1557
pubmed: 33712533
Eur Urol. 2011 Apr;59(4):572-83
pubmed: 21315502

Auteurs

Esther Mena (E)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; esther.menagonzalez@nih.gov.

Steven P Rowe (SP)

Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Joanna H Shih (JH)

Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Liza Lindenberg (L)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Baris Turkbey (B)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Aloyse Fourquet (A)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Frank I Lin (FI)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Stephen Adler (S)

Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland.

Philip Eclarinal (P)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Yolanda L McKinney (YL)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Deborah E Citrin (DE)

Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

William Dahut (W)

Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Bradford J Wood (BJ)

Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Richard Chang (R)

Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Elliot Levy (E)

Center of Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Maria Merino (M)

Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Michael A Gorin (MA)

James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Martin G Pomper (MG)

Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Peter A Pinto (PA)

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and.

Janet F Eary (JF)

Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Peter L Choyke (PL)

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Kenneth J Pienta (KJ)

James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH